Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy

Within the last decades cancer treatment improved by the availability of more specifically acting drugs that address molecular target structures in cancer cells. However, those target-sensitive drugs suffer from ongoing resistances resulting from mutations and moreover they are affected by the cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreutzer, David, Döring, Henry, Werner, Peter, Ritter, Christoph A., Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150856/
https://www.ncbi.nlm.nih.gov/pubmed/34065900
http://dx.doi.org/10.3390/ijms22105098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150856/
https://www.ncbi.nlm.nih.gov/pubmed/34065900
http://dx.doi.org/10.3390/ijms22105098

Ejemplares similares